Skip to main content
OpenTrials
Completed

NCT Number: NCT05232786

Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland

ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Novo Nordisk Investigational Site

Zurich, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

People Living with Obesity:

  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male, female or other, aged above or equal to 18 years at the time of signing informed consent
  • Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
  • Current BMI of 30 Kg/m^2 or greater calculated based on self-reported height and weight

Health Care Professionals:

  • Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
  • Male, female or other, aged above or equal to 18 years at the time of signing informed consent.
  • Physician
  • Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance
  • Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)
  • Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery
  • Practices in Switzerland
  • In clinical practice for greater than or equal to 2 years
  • Spends at least 50% time in direct patient care
  • Has seen at least 100 adult patients in past month (all physicians except psychiatrists) Has seen at least 10 patients with obesity (PCPs and General Internal Medicine with focus on Diabetes and/or obesity, Obstetrics/ Gynaecologists, Endocrinology/Diabetology or Bariatric surgery) or 5 patients with obesity (dietitians and psychiatrists) in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 Kg/m^2 with or without comorbidities.

Exclusion criteria

People Living with Obesity:

  • Previous participation in this study. Participation is defined as having given online consent in this study
  • Currently pregnant
  • Participates in intense fitness or body building programs
  • Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
  • Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers:

  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.

Treatment and study plan

No treatment given

Other

No treatment given

Primary outcomes

  1. Weight loss motivators

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  2. Proportion of PLwO who made serious weight loss effort

    Time frame: At the time of survey response (Day 1)

    Number of weight loss efforts; percentage of patients

  3. Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs

    Time frame: At the time of survey response (Day 1)

    5-point Likert scales (e.g., agreement, impact, frequency)

    • Proportion of responses in each category will be reported.

  4. Weight loss barriers

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

  5. Weight loss management

    Time frame: At the time of survey response (Day 1)

    Multi-select from defined list

Sponsors and collaborators

Lead sponsor

Novo Nordisk A/S

Industry

Registry information

Acronym: ACTION-CH

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Feb 10, 2022
Registry last updated
Oct 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.